100 Recruiting Studies Using Pemetrexed
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Pemetrexed
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage IB Lung Non-Small Cell Carcinoma AJCC v7
View Study & Checklist ➔Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
📍 Kaiser Permanente - Oakland ( Site 0054) — Oakland, California
Non-small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
📍 University of Colorado Cancer Center — Aurora, Colorado
Cancer
View Study & Checklist ➔Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
📍 Research Site — Orlando, Florida
Carcinoma
View Study & Checklist ➔Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
📍 Research Site — Phoenix, Arizona
Non Small Cell Lung Cancer NSCLC
View Study & Checklist ➔A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
📍 City of Hope 2 — Duarte, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
📍 GSK Investigational Site — Goodyear, Arizona
Neoplasms
View Study & Checklist ➔A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
📍 Southern Cancer Care — Daphne, Alabama
NSCLC
View Study & Checklist ➔Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
📍 Research Site — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
📍 Research Site — Iowa City, Iowa
Metastatic Non-Small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
📍 Research Site — Anaheim, California
Non Small Cell Lung Carcinoma NSCLC
View Study & Checklist ➔MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
📍 Research Site — Santa Rosa, California
Unresectable Pleural Mesothelioma
View Study & Checklist ➔Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
📍 Innovative Clinical Research Institute — Whittier, California
Non-small Cell Lung Cancer
View Study & Checklist ➔Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
📍 Research Site — Columbus, Georgia
Non Small Cell Lung Cancer
View Study & Checklist ➔A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
📍 Clermont Oncology Center — Clermont, Florida
Resectable Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
📍 Local Institution - 0104 — Tampa, Florida
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska
Malignant Solid Tumor
View Study & Checklist ➔TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
📍 City of Hope National Medical Center — Long Beach, California
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Resectable Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
View Study & Checklist ➔A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
📍 MD Anderson Cancer Center — Houston, Texas
Urothelial Carcinoma
View Study & Checklist ➔Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
📍 University of Alabama at Birmingham — Birmingham, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
Lung Non-Squamous Non-Small Cell Carcinoma
View Study & Checklist ➔Volrustomig Priming Regimens Exploratory Phase II Platform Study
📍 Research Site — Los Angeles, California
Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
📍 OPN Healthcare, Inc. — Glendale, California
Non-small Cell Lung Cancer
View Study & Checklist ➔Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
📍 Research Site — Phoenix, Arizona
NSCLC
View Study & Checklist ➔Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
📍 Clearview Cancer Institute — Huntsville, Alabama
Lung Cancer, Non-squamous, Non-small Cell
View Study & Checklist ➔Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
📍 Comprehensive Blood and Cancer Center — Bakersfield, California
Thoracic Tumors
View Study & Checklist ➔A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
📍 Rush University Medical Center — Chicago, Illinois
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
📍 Highlands Oncology Group - Rogers — Rogers, Arkansas
Epithelioid Mesothelioma
View Study & Checklist ➔Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
Advanced Malignancies
View Study & Checklist ➔Study of Novel Treatment Combinations in Patients With Lung Cancer
📍 Arizona Oncology Associates,Substudy-02 — Tucson, Arizona
Lung Cancer
View Study & Checklist ➔Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
📍 UCLA Hematology/Oncology - Santa Monica ( Site 0023) — Los Angeles, California
Non-small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
📍 Research Site — Anaheim, California
Non Small Cell Lung Carcinoma NSCLC
View Study & Checklist ➔A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS
📍 Research Site — Beverly Hills, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
NSCLC
View Study & Checklist ➔Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
📍 University of Florida Health Science Center - Jacksonville — Jacksonville, Florida
Stage II Non-Small Cell Lung Cancer AJCC v7
View Study & Checklist ➔A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)
📍 Local Institution - 0032 — Anchorage, Alaska
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
📍 UC Davis — Sacramento, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Plasma-Adapted First-Line Pembro In NSCLC
📍 Brigham and Women's Hospital — Boston, Massachusetts
NSCLC Stage IV
View Study & Checklist ➔A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
📍 Moffitt Cancer Center — Tampa, Florida
Mesothelioma
View Study & Checklist ➔Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Metastatic Lung Adenocarcinoma
View Study & Checklist ➔Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)
📍 St. Bernards Medical Center ( Site 0103) — Jonesboro, Arkansas
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
📍 St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023) — Phoenix, Arizona
Metastatic Non-small Cell Lung Cancer
View Study & Checklist ➔A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
📍 Research Site — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
📍 Research Site — Phoenix, Arizona
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
📍 Memoiral Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Malignant Pleural Mesothelioma
View Study & Checklist ➔A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.
📍 Research Site — Hot Springs, Arkansas
Metastatic Non-small Cell Lung Cancer
View Study & Checklist ➔Afatinib With CT and RT for EGFR-Mutant NSCLC
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Lung Cancer
View Study & Checklist ➔Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
📍 Clinical Research Facility — Duarte, California
Non-Small-Cell Lung Cancer
View Study & Checklist ➔A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
📍 Valkyrie Clinical Trials — Los Angeles, California
Non-small Cell Lung Cancer
View Study & Checklist ➔Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Biphasic Mesothelioma
View Study & Checklist ➔Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
📍 Highlands Oncology Group — Fayetteville, Arkansas
Metastatic NSCLC - Non-Small Cell Lung Cancer
View Study & Checklist ➔Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)
📍 Northwestern University Feinberg School of Medicine — Chicago, Illinois
Lung Cancer
View Study & Checklist ➔A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features
📍 Research Site — Tucson, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
📍 Research Site — Bonita Springs, Florida
Non-small Cell Lung Cancer NSCLC
View Study & Checklist ➔A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
Carcinoma, Pancreatic Ductal
View Study & Checklist ➔A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
Medulloblastoma
View Study & Checklist ➔A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
📍 Arizona Clinical Research Center — Tucson, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
📍 University of South Alabama, Mitchell Cancer Institute ( Site 0003) — Mobile, Alabama
Lung Neoplasms
View Study & Checklist ➔Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Advanced Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
📍 Banner MD Anderson Cancer Center ( Site 0028) — Gilbert, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
📍 Highlands Oncology Group — Fayetteville, Arkansas
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
📍 Centro de Oncología e Investigación de Buenos Aires — Berazategui, Buenos Aires
Non-Small Cell Lung Cancer
View Study & Checklist ➔MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Metastatic Salivary Gland Carcinoma
View Study & Checklist ➔A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
📍 Southern Cancer Center, PC — Mobile, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
📍 Southern Cancer Center Pc — Daphne, Alabama
Metastatic Non Small Cell Lung Cancer
View Study & Checklist ➔A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
📍 Research Site — Anchorage, Alaska
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
📍 Research Site — Detroit, Michigan
Selected Advanced Solid Tumors
View Study & Checklist ➔A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
Advanced Solid Tumor
View Study & Checklist ➔Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)
📍 Research Site — Scottsdale, Arizona
Non-Small-Cell Lung Carcinoma NSCLC
View Study & Checklist ➔A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Lung Cancer
View Study & Checklist ➔A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
📍 USA Mitchell Cancer Institute-Clinical Trials ( Site 4126) — Mobile, Alabama
Cervical Cancer
View Study & Checklist ➔A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
📍 Research Site — Bellflower, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Recurrent Non-Small Cell Lung Carcinoma
View Study & Checklist ➔Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Lung Non-Squamous Non-Small Cell Carcinoma
View Study & Checklist ➔Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
📍 Cleveland Clinic, Case Comprehensive Cancer Center — Cleveland, Ohio
Large B-cell Lymphoma
View Study & Checklist ➔Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
📍 Local Institution - 0212 — Beverly Hills, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Using ctDNA to Determine Therapies for Lung Cancer
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Non Small Cell Lung Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
📍 Alaska Oncology and Hematology — Anchorage, Alaska
Non-Small Cell Lung Cancer
View Study & Checklist ➔Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Non-Small Cell Lung Cancer, NSCLC
View Study & Checklist ➔BBO-11818 in Adult Subjects With KRAS Mutant Cancer
📍 The Angeles Clinic and Research Institute - West Los Angeles Office — Los Angeles, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
📍 Moffitt Cancer Center ( Site 0261) — Tampa, Florida
Advanced Solid Tumors
View Study & Checklist ➔A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
📍 Banner MD Anderson Cancer Center ( Site 0181) — Gilbert, Arizona
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
📍 Research Site — Little Rock, Arkansas
Non-small Cell Lung Cancer
View Study & Checklist ➔Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
📍 Southern Cancer Center (SCC) ( Site 8004) — Daphne, Alabama
Lung Neoplasm Malignant
View Study & Checklist ➔A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
📍 Southern Cancer Center, P.C. — Daphne, Alabama
Non Small Cell Lung Cancer (Squamous or Non Squamous)
View Study & Checklist ➔LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
📍 University of Illinois Cancer Center — Chicago, Illinois
NSCLC
View Study & Checklist ➔Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
📍 Northwestern University — Chicago, Illinois
Metastatic Bladder Urothelial Carcinoma
View Study & Checklist ➔Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
📍 UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California
Solid Tumor, Adult
View Study & Checklist ➔Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
📍 Lombardi Comprehensive Cancer Center, Georgetown University — Washington D.C., District of Columbia
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
📍 Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina
Nonsmall Cell Lung Cancer
View Study & Checklist ➔Pan Tumor Rollover Study
📍 Local Institution - 0220 — Huntsville, Alabama
Cancer
View Study & Checklist ➔A Study of ASP1002 in Adults for Treatment of Solid Tumors
📍 Yale University Cancer Center — New Haven, Connecticut
Advanced Solid Tumors
View Study & Checklist ➔